EPO and neoplasm: Signalling through the growth factor receptor tyrosine kinase pathway in PR(−) tumours was indicated previously.28 ERK phosphorylation was significantly reduced after long-term treatment, indicating that cells are non-responsive to Epo stimulation, probably due to saturation of MAPK signalling pathway or regulation of cytosolic phospholipase A2.50